Vriglim-MP 1 Tablet SR
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Vriglim-MP 1 Tablet SR
Glycemic control in adults with type 2 diabetes mellitus is aided by the combined-action medication, Vriglim-MP 1 Tablet SR. This extended-release tablet complements dietary and exercise regimens to enhance blood glucose management. Its mechanism involves improving insulin efficacy, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and duration. Take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case, omit the missed dose and resume the regular schedule. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals increases hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should consult their physician. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption as it may heighten side effect incidence.
Primary Ingredients of Vriglim-MP 1 Tablet SR
No text provided. Please provide the text you want me to rephrase.
Uses of Vriglim-MP 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Vriglim-MP 1 Tablet SR:
Consume this medication according to your physician's prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vriglim-MP 1 Tablet SR with a meal.
Common Side effects of Vriglim-MP 1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Vriglim-MP 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vriglim-MP 1 Tablet SR should be administered with a meal.
How Vriglim-MP 1 Tablet SR works:
Vriglim-MP SR, a single-tablet formulation, combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their complementary mechanisms synergistically manage blood glucose levels when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Vriglim-MP 1 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vriglim-MP 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Vriglim-MP 1 Tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Vriglim-MP 1 Tablet SR, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Vriglim-MP 1 Tablet SR. Physician consultation is recommended. Kidney function should be regularly monitored during treatment with this medication.
LiverCAUTION
Patients with hepatic impairment should use Vriglim-MP 1 Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. Vriglim-MP 1 Tablet SR is contraindicated in individuals with severe liver dysfunction.
What if you forget to take Vriglim-MP 1 Tablet SR :
Should you forget to take a Vriglim-MP 1 Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vriglim-MP 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently